Search This Blog

Monday, October 28, 2013

Promising Phase IIb Data On Clazakizumab In Patients With Moderate-To-Severe Rheumatoid Arthritis To Be Presented At The 2013 Annual Meeting Of The American College Of Rheumatology | BMS Newsroom

Promising Phase IIb Data On Clazakizumab In Patients With Moderate-To-Severe Rheumatoid Arthritis To Be Presented At The 2013 Annual Meeting Of The American College Of Rheumatology | BMS Newsroom

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.